Literature DB >> 10051628

Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells.

A J Puren1, G Fantuzzi, C A Dinarello.   

Abstract

Interleukin (IL)-18, formerly called interferon gamma (IFN-gamma)-inducing factor, is biologically and structurally related to IL-1beta. A comparison of gene expression, synthesis, and processing of IL-18 with that of IL-1beta was made in human peripheral blood mononuclear cells (PBMCs) and in human whole blood. Similar to IL-1beta, the precursor for IL-18 requires processing by caspase 1. In PBMCs, mature but not precursor IL-18 induces IFN-gamma; in whole human blood stimulated with endotoxin, inhibition of caspase 1 reduces IFN-gamma production by an IL-1beta-independent mechanism. Unlike the precursor for IL-1beta, precursor for IL-18 was expressed constitutively in PBMCs and in fresh whole blood from healthy human donors. Western blotting of endotoxin-stimulated PBMCs revealed processed IL-1beta in the supernatants via an caspase 1-dependent pathway. However, in the same supernatants, only unprocessed precursor IL-18 was found. Unexpectedly, precursor IL-18 was found in freshly obtained PBMCs and constitutive IL-18 gene expression was present in whole blood of healthy donors, whereas constitutive IL-1beta gene expression is absent. Similar to human PBMCs, mouse spleen cells also constitutively contained the preformed precursor for IL-18 and expressed steady-state IL-18 mRNA, but there was no IL-1beta protein and no spontaneous gene expression for IL-1beta in these same preparations. We conclude that although IL-18 and IL-1beta are likely members of the same family, constitutive gene expression, synthesis, and processing are different for the two cytokines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051628      PMCID: PMC26770          DOI: 10.1073/pnas.96.5.2256

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma.

Authors:  H J Ahn; S Maruo; M Tomura; J Mu; T Hamaoka; K Nakanishi; S Clark; M Kurimoto; H Okamura; H Fujiwara
Journal:  J Immunol       Date:  1997-09-01       Impact factor: 5.422

2.  Biologically active, alternatively processed interleukin-1 beta in psoriatic scales.

Authors:  E N Lundqvist; T Egelrud
Journal:  Eur J Immunol       Date:  1997-09       Impact factor: 5.532

3.  Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes.

Authors:  S Stoll; G Müller; M Kurimoto; J Saloga; T Tanimoto; H Yamauchi; H Okamura; J Knop; A H Enk
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

Review 4.  IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family.

Authors:  C A Dinarello
Journal:  J Allergy Clin Immunol       Date:  1999-01       Impact factor: 10.793

5.  Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor.

Authors:  M Baier; N Bannert; A Werner; K Lang; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB.

Authors:  D Robinson; K Shibuya; A Mui; F Zonin; E Murphy; T Sana; S B Hartley; S Menon; R Kastelein; F Bazan; A O'Garra
Journal:  Immunity       Date:  1997-10       Impact factor: 31.745

7.  Response to local inflammation of IL-1 beta-converting enzyme- deficient mice.

Authors:  G Fantuzzi; G Ku; M W Harding; D J Livingston; J D Sipe; K Kuida; R A Flavell; C A Dinarello
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

8.  Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production.

Authors:  T Ghayur; S Banerjee; M Hugunin; D Butler; L Herzog; A Carter; L Quintal; L Sekut; R Talanian; M Paskind; W Wong; R Kamen; D Tracey; H Allen
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

9.  Human monocyte ATP-induced IL-1 beta posttranslational processing is a dynamic process dependent on in vitro growth conditions.

Authors:  R E Laliberte; D G Perregaux; P McNiff; C A Gabel
Journal:  J Leukoc Biol       Date:  1997-08       Impact factor: 4.962

10.  Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells.

Authors:  K Akita; T Ohtsuki; Y Nukada; T Tanimoto; M Namba; T Okura; R Takakura-Yamamoto; K Torigoe; Y Gu; M S Su; M Fujii; M Satoh-Itoh; K Yamamoto; K Kohno; M Ikeda; M Kurimoto
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

View more
  126 in total

1.  Seeligeriolysin O, a cholesterol-dependent cytolysin of Listeria seeligeri, induces gamma interferon from spleen cells of mice.

Authors:  Yutaka Ito; Ikuo Kawamura; Chikara Kohda; Hisashi Baba; Takamasa Nomura; Terumi Kimoto; Isao Watanabe; Masao Mitsuyama
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Changes of inflammation-associated cytokine expressions during early phase of experimental endotoxic shock in macaques.

Authors:  Xiao-Hui Ji; Ke-Yi Sun; Yan-Hong Feng; Guo-Qing Yin
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

3.  The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription.

Authors:  Ariel Werman; Rachel Werman-Venkert; Rosalyn White; Jae-Kwon Lee; Batsheva Werman; Yakov Krelin; Elena Voronov; Charles A Dinarello; Ron N Apte
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

4.  NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8⁺ T cells.

Authors:  Andreas Kupz; Greta Guarda; Thomas Gebhardt; Leif E Sander; Kirsty R Short; Dimitri A Diavatopoulos; Odilia L C Wijburg; Hanwei Cao; Jason C Waithman; Weisan Chen; Daniel Fernandez-Ruiz; Paul G Whitney; William R Heath; Roy Curtiss; Jürg Tschopp; Richard A Strugnell; Sammy Bedoui
Journal:  Nat Immunol       Date:  2012-01-08       Impact factor: 25.606

5.  Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice.

Authors:  Julia Menke; Tillmann Bork; Birte Kutska; Katelyn T Byrne; Michaela Blanfeld; Manfred Relle; Vicki R Kelley; Andreas Schwarting
Journal:  Kidney Int       Date:  2010-10-27       Impact factor: 10.612

6.  Blocking of interferon regulatory factor 1 reduces tumor necrosis factor α-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein a: role of the nuclear interferon regulatory factor 1-NF-κB-c-jun complex.

Authors:  Hubert Marotte; Pei-Suen Tsou; Bradley J Rabquer; Adam J Pinney; Tatiana Fedorova; Nalin Lalwani; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2011-11

7.  TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin.

Authors:  Matam Vijay-Kumar; Frederic A Carvalho; Jesse D Aitken; Nimita H Fifadara; Andrew T Gewirtz
Journal:  Eur J Immunol       Date:  2010-12       Impact factor: 5.532

8.  Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients.

Authors:  A Kaser; D Novick; M Rubinstein; B Siegmund; B Enrich; R O Koch; W Vogel; S H Kim; C A Dinarello; H Tilg
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 9.  Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.

Authors:  Laura C O'Brien; Eleonora Mezzaroma; Benjamin W Van Tassell; Carlo Marchetti; Salvatore Carbone; Antonio Abbate; Stefano Toldo
Journal:  Mol Med       Date:  2014-06-12       Impact factor: 6.354

10.  Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor.

Authors:  Eli C Lewis; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.